The revamped Prime Video ‘Ultra’ tier will cost $4.99 per month and come with ‘exclusive’ access to 4K streams. is a news ...

Add Yahoo as a preferred source to see more of our stories on Google. Things you buy through our links may earn Vox Media a commission. It's rare for a product to be so innovative that it truly ...

SINGAPORE – At the close of the latest Build-To-Order (BTO) sales exercise in February, all first-time buyers of three- and four-room flats in Toa Payoh’s Kim Keat Crest were virtually guaranteed the ...

Streaming devices might seem like a needless luxury, but they can be a lifesaver for a lot of TVs. While you’re likely already able to access plenty of services on your televisi ...

Castor Financial’s Prime PLUS loan program is designed to redefine wholesale lending by streamlining the complexities of non-QM financing for brokers and their clients. This versatile program empowers ...

First introduced in 2025 as an Early Access program, Alexa+ has officially rolled out on all Alexa-enabled devices and, as of yesterday, with three distinct communication styles. By Erin Lassner ...

Bring your deals, scenarios and questions as National Mortgage Professional Magazine presents a DealDesk featuring Castor Financial’s Prime PLUS loan program. Come join this interactive forum where ...

Attila covers software, apps and services, with a focus on virtual private networks. He's an advocate for digital privacy and has been quoted in online publications like Computer Weekly, The Guardian, ...

Event-free survival improved with EV/pembro: median not reached vs 48.5 months, and 24‑month EFS 79.4% vs 66.2% with cisplatin/gemcitabine. Overall survival separated early (24‑month 86.9% vs 81.3%), ...

ResQ133A-NMIBC: A phase 1/2 clinical trial of intravesical recombinant mycobacterium bacillus Calmette-Guerin (rBCG) in participants living with non-muscle invasive bladder cancer eligible to receive ...

Preliminary results from phase II enfortumab vedotin plus toripalimab compared to gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC). This is an ASCO ...